Galectin-8 and galectin-9, as modulators of autophagy and immune checkpoint pathways, respectively, present dual opportunities: first, as indicators of the host’s autophagic and immunoregulatory responses to infection and, second, as therapeutic targets to enhance bacterial clearance or modulate pathological inflammation [89,165]. The gene discussed is LGALS8; the disease is infection.